Market Analysis

The IV infusion equipment market covers the global market for devices and products specially designed to administer fluids, medications, or therapeutic agents via veins in a patient's body. These devices are of great importance in a wide range of healthcare settings, from hospitals to medical centers and health services at home. The market for IV infusion equipment covering a broad range of instruments and products to administer liquids, medications or treatments directly in the patient's vein is an important part of the worldwide healthcare industry. In a variety of healthcare settings, including hospitals, doctor's offices, rehabilitation centers and home care which serve all age groups and illnesses, this market has an important role. These devices are used to monitor the rate and volume of fluids or medicinal products delivered through an IV so as to be sure that they are administered accurately and precisely. They are especially important for patients requiring periodic infusion therapy in the intensive care units, surgery settings and to patients with continuous infusion therapy. The increasing prevalence of chronic diseases, such as cardiovascular disorders, cancer, and diabetes, has led to a rise in the demand for IV therapies. In addition, access to health services has been increased and IV equipment is used more widely in developing countries due to the development of healthcare infrastructure. According to the research report "Global Intravenous Equipment Market Research Report, 2031," published by Actual Market Research, the Global Intravenous Equipment market was valued at more than USD 16.72 Billion in 2025, and expected to reach a market size of more than USD 23.99 Billion by 2031 with the CAGR of 6.37% from 2026-2031. Recent strategic acquisitions highlight market expansion BD acquired Edwards Lifesciences critical care assets for 4.2 billion dollars to integrate monitoring with infusion delivery while Strykers 4.9 billion dollar purchase of Inari Medical secures its entry into peripheral vascular infusion therapies signaling an expansion beyond traditional orthopedics. Regulatory stringency raises operating thresholds, and smaller firms like InfuTronix exited the market after recalling 52,328 Nimbus units, highlighting the financial risks associated with quality lapses.

Platform strategies that integrate infusion pumps, disposables, and analytics create sticky ecosystems that increase switching costs for healthcare providers, and strengthen customer loyalty. AI capabilities have emerged as key competitive differentiators, with BD’s HemoSphere Alta offering real time cerebral autoregulatory insights, and Baxter enhancing its Spectrum IQ system with dose change alerts and remote monitoring features. White space opportunities remain significant in home infusion monitoring and mid tier emerging markets, where optimized systems cost can provide effective alternatives to premium devices while maintaining safety and efficiency. Cybersecurity compliance and software as a medical device expertise are becoming essential requirements for new entrants, as connected infusion systems grow in adoption. Globally, the IV therapy devices market is experiencing increased competition driven by technological innovation, rising demand for outpatient and home based therapy, and the need for enhanced patient safety and infection control. .

Market Dynamic

Segmentation

IV catheters dominate the global intravenous equipment market due to their essential role in enabling vascular access for a wide range of clinical therapies and their widespread use across hospitals and homecare settings.

IV catheters are indispensable in virtually every healthcare setting, from emergency care and intensive care units to oncology, dialysis, and general wards, making them the most frequently used intravenous product type. Hospitals, which account for the largest portion of intravenous equipment utilization, rely heavily on catheters for short term and long term vascular access, as patients often require multiple infusions simultaneously or sequentially, necessitating the use of high quality, reliable catheters to ensure treatment efficacy and patient safety. The widespread prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and kidney disease has significantly contributed to the demand for IV catheters, as these conditions often require repeated or continuous intravenous therapy over extended periods. Additionally, the rise in surgical procedures and critical care interventions worldwide further increases the need for dependable vascular access, positioning IV catheters as a central component of hospital operations and patient management. Safety concerns and infection prevention also reinforce the demand for advanced catheter technologies, including needleless connectors, antimicrobial coated catheters, and closed system designs that minimize contamination risk and reduce the incidence of catheter associated bloodstream infections. Technological advancements in catheter design, materials, and insertion techniques have improved patient comfort, reduced complications, and enhanced overall clinical outcomes, encouraging healthcare providers to adopt premium and specialized catheter products.

Hospitals and clinics including dialysis centers are the largest application segment in the global intravenous equipment market because they provide the infrastructure and patient volume necessary for continuous therapy.

Hospitals and clinics including dialysis centers dominate the global intravenous equipment market as the primary end users due to their central role in delivering intravenous therapies across a wide spectrum of medical conditions. These healthcare facilities manage acute, chronic, and critical care cases that require precise administration of fluids, medications, blood transfusions, and nutritional support, often simultaneously across multiple departments such as intensive care units, emergency rooms, surgical suites, oncology wards, and general wards. The high patient turnover and complexity of treatments in hospitals ensure a consistent and substantial demand for intravenous equipment including infusion pumps, catheters, administration sets, securement devices, and safety systems, which are essential for maintaining clinical accuracy, preventing infections, and improving patient outcomes. Dialysis centers embedded within hospitals contribute significantly to this demand, as intravenous access is critical for managing chronic kidney disease patients who require regular hemodialysis or peritoneal dialysis, with procedures demanding precise fluid management and continuous monitoring by skilled healthcare professionals. The rising prevalence of non communicable diseases such as cardiovascular disorders, diabetes, cancer, and renal failure globally has increased hospital admissions and the necessity for frequent intravenous interventions, reinforcing the dominance of this application segment. Hospitals and clinics possess the necessary infrastructure and trained personnel to handle advanced intravenous technologies including integrated closed systems, needleless connectors, AI enabled infusion pumps, and safety IV devices, which are often beyond the scope of smaller clinics or homecare settings.

Safety IV devices are the largest technology segment in the global intravenous equipment market because they minimize needlestick injuries and reduce the risk of bloodborne infections, ensuring safer intravenous therapy for patients.

Needlestick injuries have long been recognized as a serious risk in clinical settings, potentially exposing healthcare workers to infectious pathogens such as hepatitis B, hepatitis C, and HIV, which has driven hospitals, clinics, and homecare providers to adopt devices designed to reduce these risks. Regulatory mandates such as the Needlestick Safety and Prevention Act in the United States and similar guidelines issued by the European Union, World Health Organization, and other national health authorities require the use of engineered safety devices in medical procedures involving intravenous therapy, which has significantly fueled market adoption. Safety IV devices encompass a wide range of products including retractable needles, needleless connectors, and integrated closed systems, all designed to prevent accidental needle exposure during insertion, manipulation, and disposal. Hospitals, dialysis centers, and outpatient care facilities have increasingly implemented these devices to comply with regulatory requirements, protect staff, and enhance patient safety, making them a core element of intravenous therapy infrastructure. Technological advancements in the safety IV segment have enhanced device usability, reduced clinical errors, and improved patient comfort, with features such as automatic needle retraction, color coded connectors, and ergonomic designs that streamline workflow for nurses and clinicians. Moreover, the integration of safety devices with smart infusion systems and closed system technologies helps minimize contamination risk, reduce catheter associated infections, and support compliance with hospital infection control protocols.

Market Regional Insights

North America is the fastest growing region in the global intravenous equipment market due to advanced healthcare infrastructure and strong regulatory support for patient safety and infection control.

The region is characterized by a large number of hospitals with sophisticated intensive care units, emergency departments, oncology centers, and dialysis facilities, all of which require continuous intravenous therapy for fluid management, medication administration, blood transfusions, and nutritional support. Technological advancement is a major growth factor, with the region leading in the development and adoption of smart infusion pumps, integrated closed systems, needleless connectors, and AI enabled monitoring devices, which improve workflow efficiency, enhance patient safety, and reduce medication errors. Regulatory frameworks enforced by authorities such as the US Food and Drug Administration and Health Canada ensure that intravenous devices meet stringent quality, performance, and safety standards, which drives healthcare providers to adopt advanced IV equipment confidently. Government policies and hospital initiatives focusing on infection prevention, needlestick injury reduction, and patient safety further accelerate the demand for safety IV devices, retractable needles, and closed system technologies, reinforcing North America’s leadership in the market. The aging population and rising prevalence of chronic diseases including cancer, cardiovascular disorders, diabetes, and renal failure contribute significantly to the demand for frequent and long term intravenous therapy, supporting sustained growth in the region. The trend toward homecare and outpatient IV therapy is particularly strong in North America, as patients and caregivers increasingly prefer treatment in home settings facilitated by portable infusion pumps and prefilled IV systems, which allow for continuous therapy outside hospital environments.